Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1–10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.

Na minha lista:
Detalhes bibliográficos
Publicado no:J Microbiol Immunol Infect
Main Authors: Cheng, Chien-Yu, Lee, Yu-Lin, Chen, Cheng-Pin, Lin, Yi-Chun, Liu, Chun-Eng, Liao, Chia-Hung, Cheng, Shu-Hsing
Formato: Artigo
Idioma:Inglês
Publicado em: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7194913/
https://ncbi.nlm.nih.gov/pubmed/32331982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmii.2020.03.032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados